Evidence map›Paper›PMID 29064128›Full record

Trial reportNephrology (Carlton, Vic.)2019

Association between change in serum bicarbonate and change in thyroid hormone levels in patients receiving conventional or more frequent maintenance haemodialysis.

Alessio Molfino, Gerald J Beck, Minwei Li, Joan C Lo, George A Kaysen, FHN Investigators

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nephrology (Carlton, Vic.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alessio MolfinoDivision of Nephrology, Department of Internal Medicine, University of California, Davis, California, USA.
Gerald J BeckDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Minwei LiDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Joan C LoDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
George A KaysenDivision of Nephrology, Department of Internal Medicine, University of California, Davis, California, USA.
FHN Investigators
Cleveland Clinic · USUniversity of California, Davis · USKaiser Permanente · US

Funding

Frequent Hemodialysis Network Data Coordinating CenterU01DK066597 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI BECK, GERALD J · 2003 to 2010
$8.9M
Frequent Hemodialysis Network - West Coast ConsortiumU01DK066481 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHERTOW, GLENN MATTHEW · 2003 to 2010
$5.2M
The Short-Daily Hemodialysis Pilot StudyU01DK066579 · NIDDK · RENAL RESEARCH INSTITUTE, LLC · PI LEVIN, NATHAN W · 2003 to 2010
$5.0M
Frequent Hemodialysis Network (FHN) - Nocturnal Clinical Core ConsortiumU01DK066480 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ROCCO, MICHAEL V · 2003 to 2010
$3.7M
ESRD Endocrinopathy and Daily DialysisR01DK076165 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI LO, JOAN C · 2010 to 2012
$659k
AmgenBaxterCenters for Medicare and Medicaid ServicesDaVitaDialysis Clinics, Inc.Fresenius Medical Care North AmericaNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of Health R01 DK076165National Institutes of Health U01 DK066480National Institutes of Health U01 DK066481National Institutes of Health U01 DK066579National Institutes of Health U01 DK066597National Institutes of Health Research FoundationNIDDK NIH HHS R01 DK076165NIDDK NIH HHS U01 DK066480NIDDK NIH HHS U01 DK066481NIDDK NIH HHS U01 DK066579NIDDK NIH HHS U01 DK066597Renal Research Institute and Satellite HealthcareThe Frequent Hemodialysis Network Trials NCT00264758The Frequent Hemodialysis Network Trials NCT00271999
6 · The paper itself

Abstract

aimCorrection of metabolic acidosis in patients with chronic kidney disease has been associated with improvement in thyroid function. We examined whether changes in bicarbonate were associated with changes in thyroid function in patients with end-stage renal disease receiving conventional or more frequent haemodialysis.

methodsIn the Frequent Hemodialysis Network Trials, the relationship between changes in serum bicarbonate, free triiodothyronine (FT3) and free thyroxine (FT4) was examined among 147 and 48 patients with endogenous thyroid function who received conventional (3×/week) or more frequent (6×/week) haemodialysis (Daily Trial) or who received conventional or more frequent nocturnal haemodialysis (Nocturnal Trial). Equilibrated normalized protein catabolic rate (enPCR) was examined to account for nutritional factors affecting both acid load and thyroid function.

resultsIncreasing dialysis frequency was associated with increased bicarbonate level. Baseline bicarbonate level was not associated with baseline FT3 and FT4. Change in bicarbonate level was not associated with changes in FT3 and FT4 in the Daily Trial nor for FT4 in the Nocturnal Trial (r ≤ 0.14, P > 0.21). While, a significant correlation between change in serum bicarbonate and change in FT3 (r = 0.44, P = 0.02) was observed in the Nocturnal Trial; findings were no longer significant after adjusting for change in enPCR (r = 0.37, P = 0.08). For participants with baseline bicarbonate <23 mmol/L, no association between change in bicarbonate and change in thyroid indices were seen in the Daily Trial; for the Nocturnal Trial, findings were also not significant for change in FT3 and the association between change in bicarbonate and change in FT4 (r = 0.54, P = 0.03) was no longer significant after adjusting for enPCR (r = 0.45, P = 0.11).

conclusionChanges in bicarbonate were not associated with changes in thyroid hormone levels after adjusting for enPCR, as a marker of nutritional status. Future studies should examine whether improvement in acid base status improves thyroid function in haemodialysis patients with evidence of thyroid hypofunction.

Indexed as

Acid-Base EquilibriumAcidosisAdultAgedBicarbonatesBiomarkersFemaleHemodialysis, HomeHumansKidney Failure, ChronicMaleMiddle AgedNutritional StatusProspective StudiesProtein-Energy MalnutritionRenal DialysisBicarbonatesBiomarkersThyroxineTriiodothyroninebicarbonateequilibrated normalized protein catabolic ratehaemodialysishypothyroidismmetabolic acidosisthyroid function

Identifiers

PMID29064128
PMCPMC5916580
OpenAlexW2766000118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.